LRS Outflows Surge Over 10 in March 2026 as Travel Demand and Investments Drive Capital Abroad Paul McCartneys Final Appearance Highlights CBSs Financial Decision to End Colberts Late Show Sell in May Pattern May Influence Crypto Markets as Seasonal Headwinds Approach Satirical Cockroach Party Reports Website Blocked Potential Free Speech and Regulatory Concerns in India Goldman Sachs Exits Apple Card Partnership Stock Enters Potential Buy Zone Alibaba Unveils NextGen Zhenwu AI Chip and New Large Language Model ZGN Q4 2025 Earnings EPS Beat Drives Stock Higher Despite Revenue Disclosures Lacking Genprex GNPX Q1 2026 Earnings Continued RD Investment as Gene Therapy Pipeline Progresses RIGL Q1 2026 Earnings EPS Misses Estimates by 369 Stock Slips aka Brands Holding Corp AKA Q1 2026 Earnings NarrowerThanExpected Loss Drives Modest Stock Uptick STLA Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Operational Challenges VRSN Q1 2026 Earnings Earnings Beat Expectations Driven by Domain Base Stability Agriculture Natural Solutions Acquisition Corporation ANSC Holds Steady at 1136 Trading Within Established Range Novanta NOVT Shares Surge 311 as Recovery Tests Key Resistance at 16769 Mayville Engineering MEC Surges 7 Key Levels and Technical Outlook CCLDO Preferred Shares Hold Steady at 2744 as Fixed Income Dynamics Support Stability FG Imperii Acquisition Corp FGII Holds Steady Near Trust Value as SPAC Investors Await Merger Catalyst Rail Vikas Nigam Suzlon ONGC Among Key Companies Set to Declare Q4 Results Next Week AMTD Q4 2020 Earnings EPS Surges Past Estimates Amid Strong Performance Sphere Entertainment SPHR Fades From Resistance A Test of Support Levels GLMD Q4 2025 Earnings EPS Misses Estimates as PreRevenue Biotech Faces Challenges SLVM Q1 2026 Earnings EPS Misses Estimates by Wide Margin Amid Industry Headwinds Syndax Pharmaceuticals Q1 2026 Earnings Narrowed Loss Beats Estimates as Pipeline Progress Continues FOLD Q4 2025 Earnings EPS Falls Short of Estimates Stock Unchanged HCXY Q1 2026 Earnings Slight EPS Miss Triggers Modest Price Gain SVRA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Pipeline Development NEU Q1 2026 Earnings Strong EPS of 1262 Shares Advance 332